2014 Q2 Form 10-K Financial Statement
#000114420414028378 Filed on May 08, 2014
Income Statement
| Concept | 2014 Q2 | 2014 | 2013 Q3 |
|---|---|---|---|
| Revenue | $4.094M | $10.48M | $2.521M |
| YoY Change | 56.6% | 34.83% | 52.86% |
| Cost Of Revenue | $3.260M | $9.076M | $2.258M |
| YoY Change | 32.63% | 43.7% | 87.28% |
| Gross Profit | $834.6K | $1.408M | $226.7K |
| YoY Change | 432.42% | -3.55% | -48.93% |
| Gross Profit Margin | 20.38% | 13.43% | 8.99% |
| Selling, General & Admin | $2.000M | $11.30M | $1.600M |
| YoY Change | 53.85% | 1312.5% | 220.0% |
| % of Gross Profit | 239.62% | 802.5% | 705.92% |
| Research & Development | |||
| YoY Change | |||
| % of Gross Profit | |||
| Depreciation & Amortization | $11.90K | $31.36K | $6.528K |
| YoY Change | 87.24% | 49.92% | 31.99% |
| % of Gross Profit | 1.43% | 2.23% | 2.88% |
| Operating Expenses | $5.281M | $14.39M | $3.308M |
| YoY Change | 20.4% | 306.79% | 552.73% |
| Operating Profit | -$1.187M | -$3.910M | -$786.6K |
| YoY Change | -33.02% | 88.11% | 1148.08% |
| Interest Expense | $276.9K | $679.2K | $200.6K |
| YoY Change | 71.23% | -26.98% | -10.82% |
| % of Operating Profit | |||
| Other Income/Expense, Net | -$309.3K | -$629.5K | -$194.1K |
| YoY Change | 92.57% | -90.77% | -93.82% |
| Pretax Income | -$1.496M | -$4.539M | -$980.7K |
| YoY Change | -22.57% | -48.99% | -69.37% |
| Income Tax | $11.60K | $19.51K | $0.00 |
| % Of Pretax Income | |||
| Net Earnings | -$1.678M | -$5.020M | -$980.7K |
| YoY Change | -13.2% | -43.62% | -69.38% |
| Net Earnings / Revenue | -40.98% | -47.88% | -38.9% |
| Basic Earnings Per Share | -$0.03 | ||
| Diluted Earnings Per Share | -$346.9K | -$367.3K | -$0.03 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 49.13M shares | 36.35M shares | |
| Diluted Shares Outstanding | 36.35M shares |
Balance Sheet
| Concept | 2014 Q2 | 2014 | 2013 Q3 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $11.93M | $5.000M | $1.300M |
| YoY Change | 645.78% | -26.47% | 333.33% |
| Cash & Equivalents | $5.762M | $5.000M | $1.075M |
| Short-Term Investments | $6.170M | ||
| Other Short-Term Assets | $100.0K | $800.0K | $0.00 |
| YoY Change | -50.0% | ||
| Inventory | |||
| Prepaid Expenses | $59.66K | $33.57K | |
| Receivables | $1.531M | $3.800M | $1.426M |
| Other Receivables | $0.00 | $200.0K | $0.00 |
| Total Short-Term Assets | $7.840M | $9.900M | $2.752M |
| YoY Change | 161.33% | 17.86% | 103.55% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $99.22K | $600.0K | $66.88K |
| YoY Change | -0.78% | 500.0% | 51.35% |
| Goodwill | $278.1K | $33.20K | |
| YoY Change | 3.75% | ||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $38.68K | $1.000M | $40.98K |
| YoY Change | -80.66% | 150.0% | 2726.28% |
| Total Long-Term Assets | $965.4K | $5.100M | $384.7K |
| YoY Change | 141.36% | 363.64% | 232.66% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $7.840M | $9.900M | $2.752M |
| Total Long-Term Assets | $965.4K | $5.100M | $384.7K |
| Total Assets | $8.805M | $15.00M | $3.137M |
| YoY Change | 158.98% | 57.89% | 113.72% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $1.500M | $3.300M | $400.0K |
| YoY Change | 400.0% | 135.71% | 811.43% |
| Accrued Expenses | $900.0K | $600.0K | |
| YoY Change | 50.0% | 500.0% | |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | -100.0% | ||
| Long-Term Debt Due | $400.0K | $1.400M | $600.0K |
| YoY Change | -33.33% | 366.67% | -33.33% |
| Total Short-Term Liabilities | $3.149M | $6.000M | $2.243M |
| YoY Change | 36.92% | 160.87% | -49.83% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $1.000M | $7.700M | $2.200M |
| YoY Change | -50.0% | 20.31% | 1000.0% |
| Other Long-Term Liabilities | $7.700M | $2.200M | |
| YoY Change | -8.33% | ||
| Total Long-Term Liabilities | $8.700M | $9.900M | $2.200M |
| YoY Change | 335.0% | 12.5% | 214.29% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $3.149M | $6.000M | $2.243M |
| Total Long-Term Liabilities | $8.700M | $9.900M | $2.200M |
| Total Liabilities | $11.80M | $17.80M | $4.100M |
| YoY Change | 174.38% | 49.58% | -19.22% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$18.03M | -$13.40M | |
| YoY Change | 144.68% | ||
| Common Stock | $49.14K | ||
| YoY Change | |||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | -$2.755M | -$2.800M | -$999.3K |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $8.805M | $15.00M | $3.137M |
| YoY Change | 158.98% | 57.89% | 113.72% |
Cashflow Statement
| Concept | 2014 Q2 | 2014 | 2013 Q3 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$1.678M | -$5.020M | -$980.7K |
| YoY Change | -13.2% | -43.62% | -69.38% |
| Depreciation, Depletion And Amortization | $11.90K | $31.36K | $6.528K |
| YoY Change | 87.24% | 49.92% | 31.99% |
| Cash From Operating Activities | -$1.100M | -$1.478M | -$310.0K |
| YoY Change | -11100.0% | -2650.56% | -542.86% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $11.97K | $22.93K | -$10.00K |
| YoY Change | 59.05% | -49.93% | |
| Acquisitions | -$216.4K | $250.0K | |
| YoY Change | -1871.29% | ||
| Other Investing Activities | $220.0K | -$3.160M | |
| YoY Change | |||
| Cash From Investing Activities | $200.0K | -$272.9K | -$10.00K |
| YoY Change | 761.39% | ||
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | -$730.0K | ||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | -180.0K | $2.026M | 0.000 |
| YoY Change | -146.15% | 105.44% | |
| NET CHANGE | |||
| Cash From Operating Activities | -1.100M | -$1.478M | -310.0K |
| Cash From Investing Activities | 200.0K | -$272.9K | -10.00K |
| Cash From Financing Activities | -180.0K | $2.026M | 0.000 |
| Net Change In Cash | -1.080M | $274.7K | -320.0K |
| YoY Change | -370.0% | -72.87% | -557.14% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$1.100M | -$1.478M | -$310.0K |
| Capital Expenditures | $11.97K | $22.93K | -$10.00K |
| Free Cash Flow | -$1.112M | -$1.501M | -$300.0K |
| YoY Change | -45082.73% | -12447.91% | -528.57% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2014 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"><strong>Concentrations</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>The Company had major payors that contributed the following percentage of net revenue during the years ended January 31:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 49%; BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="24%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="24%"> <div>Payor A</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>15.9</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>22.0</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="24%"> <div>Payor B</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>15.9</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="24%"> <div>Payor C</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>15.5</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> </div> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>Receivables from these payors amounted to the following percentage of total accounts receivable, net at January 31:</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 49%; BORDER-COLLAPSE: collapse; FONT-SIZE: 10pt; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="24%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2014</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2013</div> </td> <td style="TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="24%"> <div>Payor A</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>9.9</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>11.0</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="24%"> <div>Payor B</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>31.5</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>36.0</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> </tr> <tr style="HEIGHT: 12px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="24%"> <div>Payor C</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4.5</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div> </div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8.5</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>%<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></div> </td> </tr> </table> </div> </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2014Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1451407 | USD |
| CY2013Q1 | us-gaap |
Due From Affiliate Current
DueFromAffiliateCurrent
|
5648 | USD |
| CY2014Q1 | us-gaap |
Due From Affiliate Current
DueFromAffiliateCurrent
|
1599 | USD |
| CY2013Q1 | us-gaap |
Minority Interest
MinorityInterest
|
-36503 | USD |
| CY2013Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-391379 | USD |
| CY2014Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-15581146 | USD |
| CY2013Q1 | us-gaap |
Liabilities
Liabilities
|
3614464 | USD |
| CY2014Q1 | us-gaap |
Liabilities
Liabilities
|
5652500 | USD |
| CY2014Q1 | us-gaap |
Goodwill
Goodwill
|
494700 | USD |
| CY2013Q1 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
30981 | USD |
| CY2014Q1 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
38681 | USD |
| CY2013Q1 | us-gaap |
Assets
Assets
|
3223085 | USD |
| CY2014Q1 | us-gaap |
Assets
Assets
|
3959782 | USD |
| CY2014Q1 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
1373285 | USD |
| CY2013Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
11248566 | USD |
| CY2014Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
14387552 | USD |
| CY2013Q1 | us-gaap |
Goodwill
Goodwill
|
33200 | USD |
| CY2013Q1 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
950651 | USD |
| CY2013Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-11022272 | USD |
| CY2013Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-354876 | USD |
| CY2014Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1428817 | USD |
| CY2014Q1 | us-gaap |
Minority Interest
MinorityInterest
|
-263901 | USD |
| CY2014Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-1692718 | USD |
| CY2014Q1 | us-gaap |
Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
|
97806 | USD |
| CY2013Q1 | us-gaap |
Assets Current
AssetsCurrent
|
2872122 | USD |
| CY2014 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal"> <strong>Use of Estimates</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2013Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1176727 | USD |
| CY2013Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1582505 | USD |
| CY2014Q1 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1509589 | USD |
| CY2013Q1 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
72628 | USD |
| CY2014Q1 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
53543 | USD |
| CY2013Q1 | us-gaap |
Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
|
34614 | USD |
| CY2014Q1 | us-gaap |
Assets Current
AssetsCurrent
|
3133944 | USD |
| CY2013Q1 | us-gaap |
Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
|
218640 | USD |
| CY2014Q1 | us-gaap |
Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
|
144345 | USD |
| CY2013Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
68142 | USD |
| CY2014Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
85685 | USD |
| CY2013Q1 | ameh |
Notes And Lines Of Credit Payable
NotesAndLinesOfCreditPayable
|
594765 | USD |
| CY2014Q1 | ameh |
Notes And Lines Of Credit Payable
NotesAndLinesOfCreditPayable
|
3178693 | USD |
| CY2013Q1 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
159334 | USD |
| CY2014Q1 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
0 | USD |
| CY2013Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1704750 | USD |
| CY2014Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
4551978 | USD |
| CY2013Q1 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
1909714 | USD |
| CY2014Q1 | us-gaap |
Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
|
1100522 | USD |
| CY2013Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
| CY2014Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
| CY2013Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
34844 | USD |
| CY2014Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
46953 | USD |
| CY2013Q1 | ameh |
Other Equity
OtherEquity
|
-616014 | USD |
| CY2014Q1 | ameh |
Other Equity
OtherEquity
|
-282176 | USD |
| CY2013Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
3223085 | USD |
| CY2014Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
3959782 | USD |
| CY2014 | ameh |
Service Agreement Term
ServiceAgreementTerm
|
P20Y | |
| CY2014 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
12602 | USD |
| CY2014 | us-gaap |
Payments To Minority Shareholders
PaymentsToMinorityShareholders
|
240000 | USD |
| CY2013 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
3467441 | shares |
| CY2014 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
6708531 | shares |
| CY2013Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2014Q1 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.001 | |
| CY2013Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
| CY2014Q1 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
| CY2013Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2014Q1 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2013Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2014Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
| CY2013Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
| CY2014Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
| CY2013Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
34843441 | shares |
| CY2014Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
46952469 | shares |
| CY2013Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
34843441 | shares |
| CY2014Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
46952469 | shares |
| CY2013Q1 | us-gaap |
Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
|
394915 | USD |
| CY2014Q1 | us-gaap |
Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
|
467636 | USD |
| CY2013Q1 | us-gaap |
Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
|
500023 | USD |
| CY2014Q1 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
0 | USD |
| CY2013 | us-gaap |
Revenues
Revenues
|
7776131 | USD |
| CY2013Q4 | us-gaap |
Debt Instrument Convertible Terms Of Conversion Feature
DebtInstrumentConvertibleTermsOfConversionFeature
|
The as-if converted cash option holder principal represented 22% of the total principal (88% was related to holders that elected to convert into shares) | |
| CY2013Q1 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
1909714 | USD |
| CY2014Q1 | us-gaap |
Convertible Notes Payable
ConvertibleNotesPayable
|
1100522 | USD |
| CY2013 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8904564 | USD |
| CY2014Q1 | us-gaap |
Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
|
452562 | USD |
| CY2013Q1 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
0 | USD |
| CY2013Q1 | us-gaap |
Accrued Income Taxes
AccruedIncomeTaxes
|
1087 | USD |
| CY2014Q1 | us-gaap |
Accrued Income Taxes
AccruedIncomeTaxes
|
287 | USD |
| CY2013Q1 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
9310 | USD |
| CY2014Q1 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
47722 | USD |
| CY2013Q1 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
45316 | USD |
| CY2014Q1 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
119453 | USD |
| CY2013Q2 | us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
45000 | USD |
| CY2014 | us-gaap |
Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
|
prime rate (as defined) plus 4.50% | |
| CY2014 | us-gaap |
Debt Instrument Covenant Description
DebtInstrumentCovenantDescription
|
Capital Ratio to be less than 0.80:1.00 at any time. | |
| CY2013Q4 | us-gaap |
Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
|
500000 | USD |
| CY2014 | ameh |
Minimum Consolidated Earnings Before Interest And Taxes Loss Of Third Quarter Ended October Twenty Thirteen
MinimumConsolidatedEarningsBeforeInterestAndTaxesLossOfThirdQuarterEndedOctoberTwentyThirteen
|
-900000 | USD |
| CY2014 | ameh |
Minimum Consolidated Earnings Before Interest And Taxes Loss Of Fourth Quarter Ended January Twenty Fourteen
MinimumConsolidatedEarningsBeforeInterestAndTaxesLossOfFourthQuarterEndedJanuaryTwentyFourteen
|
-1227111 | USD |
| CY2014 | ameh |
Minimum Consolidated Earnings Before Interest And Taxes Loss Of First Quarter Ended April Twenty Fourteen
MinimumConsolidatedEarningsBeforeInterestAndTaxesLossOfFirstQuarterEndedAprilTwentyFourteen
|
-1696958 | USD |
| CY2013 | us-gaap |
Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
|
83331 | USD |
| CY2014 | us-gaap |
Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
|
161091 | USD |
| CY2013 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
111290 | USD |
| CY2014 | us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
229725 | USD |
| CY2012Q1 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
|
0.11485 | |
| CY2014Q1 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
|
0.125 | |
| CY2012Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
|
0.11485 | |
| CY2013Q1 | us-gaap |
Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
|
0.125 | |
| CY2013Q4 | us-gaap |
Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
|
0.30 | |
| CY2014 | us-gaap |
Revenues
Revenues
|
10484305 | USD |
| CY2013 | us-gaap |
Cost Of Services
CostOfServices
|
6316164 | USD |
| CY2014 | us-gaap |
Cost Of Services
CostOfServices
|
9076213 | USD |
| CY2013 | us-gaap |
Gross Profit
GrossProfit
|
1459967 | USD |
| CY2014 | us-gaap |
Gross Profit
GrossProfit
|
1408092 | USD |
| CY2013 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
3517536 | USD |
| CY2014 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
5286610 | USD |
| CY2013 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
20918 | USD |
| CY2014 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
31361 | USD |
| CY2013 | us-gaap |
Operating Expenses
OperatingExpenses
|
3538454 | USD |
| CY2014 | us-gaap |
Operating Expenses
OperatingExpenses
|
5317971 | USD |
| CY2013 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2078487 | USD |
| CY2014 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-3909879 | USD |
| CY2013 | ameh |
Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
|
-5853855 | USD |
| CY2014 | ameh |
Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
|
0 | USD |
| CY2013 | us-gaap |
Interest Expense
InterestExpense
|
930176 | USD |
| CY2014 | us-gaap |
Interest Expense
InterestExpense
|
679184 | USD |
| CY2013 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
-37246 | USD |
| CY2014 | us-gaap |
Other Nonoperating Income
OtherNonoperatingIncome
|
49702 | USD |
| CY2013 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-6821277 | USD |
| CY2014 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-629482 | USD |
| CY2013 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-8899764 | USD |
| CY2014 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-4539361 | USD |
| CY2013 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
4800 | USD |
| CY2014 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
19513 | USD |
| CY2014 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
0 | |
| CY2013 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
0 | |
| CY2014 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
0.79 | |
| CY2013Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.18 | |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.17 | |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
0.16 | |
| CY2014 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4558874 | USD |
| CY2013 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
32469999 | shares |
| CY2014 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
36661648 | shares |
| CY2013 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.27 | |
| CY2014 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.12 | |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
165000 | shares |
| CY2013Q3 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
1733000 | shares |
| CY2013Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
270000 | shares |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
|
44000 | shares |
| CY2012 | us-gaap |
Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
|
600000 | shares |
| CY2012Q2 | us-gaap |
Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
|
300000 | shares |
| CY2013Q2 | us-gaap |
Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
|
100000 | shares |
| CY2012Q3 | us-gaap |
Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
|
200000 | shares |
| CY2012Q3 | us-gaap |
Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
|
3350000 | shares |
| CY2012Q2 | us-gaap |
Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
|
216000 | shares |
| CY2012Q4 | us-gaap |
Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
|
100000 | shares |
| CY2014 | us-gaap |
Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
|
220000 | USD |
| CY2013Q2 | ameh |
Aggregate Fair Value Of Stock Options
AggregateFairValueOfStockOptions
|
88170 | USD |
| CY2013Q3 | ameh |
Aggregate Fair Value Of Stock Options
AggregateFairValueOfStockOptions
|
1045984 | USD |
| CY2013Q4 | ameh |
Aggregate Fair Value Of Stock Options
AggregateFairValueOfStockOptions
|
74311 | USD |
| CY2013Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
382000 | shares |
| CY2012 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
90000 | USD |
| CY2012Q2 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
41560 | USD |
| CY2012Q3 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
26000 | USD |
| CY2013Q2 | us-gaap |
Fair Value Assumptions Exercise Price
FairValueAssumptionsExercisePrice
|
0.41 | |
| CY2013Q3 | us-gaap |
Fair Value Assumptions Exercise Price
FairValueAssumptionsExercisePrice
|
0.004 | |
| CY2013Q4 | us-gaap |
Fair Value Assumptions Exercise Price
FairValueAssumptionsExercisePrice
|
0.47 | |
| CY2013Q2 | us-gaap |
Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
|
P4Y7M2D | |
| CY2013Q3 | us-gaap |
Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
|
P3Y | |
| CY2013Q4 | us-gaap |
Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
|
P6Y | |
| CY2013Q2 | us-gaap |
Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
|
0.260 | pure |
| CY2013Q3 | us-gaap |
Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
|
0.297 | pure |
| CY2013Q4 | us-gaap |
Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
|
0.672 | pure |
| CY2013Q2 | us-gaap |
Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
|
0.0 | pure |
| CY2013Q3 | us-gaap |
Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
|
0.0 | pure |
| CY2013Q4 | us-gaap |
Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
|
0.0 | pure |
| CY2013Q2 | us-gaap |
Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
|
0.005 | pure |
| CY2013Q3 | us-gaap |
Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
|
0.006 | pure |
| CY2013Q4 | us-gaap |
Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
|
0.014 | pure |
| CY2012Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
1150000 | shares |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
4225000 | shares |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
3085000 | shares |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
|
1020250 | shares |
| CY2013 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
75000 | shares |
| CY2014 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
0 | shares |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
0 | shares |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
0 | shares |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
0 | shares |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
-6750 | shares |
| CY2013Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
5300000 | shares |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
7358000 | shares |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
6066890 | shares |
| CY2012Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
0.15 | |
| CY2013 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0.19 | |
| CY2014 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
0.18 | |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
0.22 | |
| CY2013 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0.21 | |
| CY2014 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
0 | |
| CY2013 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
0 | |
| CY2013Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
|
3690000 | shares |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
|
3752000 | shares |
| CY2013Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
0 | USD |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
0 | USD |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
|
0 | USD |
| CY2014Q1 | ameh |
Class Of Warrant Or Right Outstanding Intrinsic Value
ClassOfWarrantOrRightOutstandingIntrinsicValue
|
0 | USD |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
|
3690000 | shares |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
|
62000 | shares |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
|
0 | shares |
| CY2012 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P8Y10M24D | |
| CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P9Y1M6D | |
| CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P9Y | |
| CY2013 | ameh |
Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodWeightedAverageRemainingContractualTerm
|
P9Y2M12D | |
| CY2014 | ameh |
Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodWeightedAverageRemainingContractualTerm
|
P9Y4M24D | |
| CY2014 | ameh |
Share Based Compensation Arrangement By Share Based Payment Award Options Cancellation In Period Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancellationInPeriodWeightedAverageRemainingContractualTerm
|
P8Y7M6D | |
| CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P0Y | |
| CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P0Y | |
| CY2013 | ameh |
Share Based Compensation Arrangement By Share Based Payment Award Options Expired In Period Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodWeightedAverageRemainingContractualTerm
|
P0Y | |
| CY2014 | ameh |
Share Based Compensation Arrangement By Share Based Payment Award Options Expired In Period Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpiredInPeriodWeightedAverageRemainingContractualTerm
|
P0Y | |
| CY2013 | ameh |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodWeightedAverageRemainingContractualTerm
|
P0Y | |
| CY2014 | ameh |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited In Period Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodWeightedAverageRemainingContractualTerm
|
P9Y | |
| CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P9Y1M6D | |
| CY2012Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
0 | USD |
| CY2013 | ameh |
Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue
|
0 | USD |
| CY2014 | ameh |
Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue
|
0 | USD |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
0 | USD |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
0 | USD |
| CY2014 | ameh |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodIntrinsicValue
|
0 | USD |
| CY2013 | ameh |
Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodIntrinsicValue
|
0 | USD |
| CY2014 | ameh |
Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodIntrinsicValue
|
0 | USD |
| CY2012 | ameh |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Beginning
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning
|
P0Y | |
| CY2014 | ameh |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Beginning
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermBeginning
|
P1Y | |
| CY2013 | ameh |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermGranted
|
P1Y10M24D | |
| CY2014 | ameh |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Remaining Contractual Term Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageRemainingContractualTermGranted
|
P1Y8M12D | |
| CY2012Q1 | ameh |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue
|
0 | USD |
| CY2013 | ameh |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted In Period Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedInPeriodAggregateIntrinsicValue
|
36900 | USD |
| CY2014 | ameh |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted In Period Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedInPeriodAggregateIntrinsicValue
|
620 | USD |
| CY2013Q1 | ameh |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue
|
36900 | USD |
| CY2014Q1 | ameh |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAggregateIntrinsicValue
|
37520 | USD |
| CY2012Q1 | ameh |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageFairValue
|
0 | |
| CY2013 | ameh |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted In Period Weighted Average Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedInPeriodWeightedAverageFairValue
|
0.01 | |
| CY2014 | ameh |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted In Period Weighted Average Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedInPeriodWeightedAverageFairValue
|
0.01 | |
| CY2013Q1 | ameh |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageFairValue
|
0.01 | |
| CY2014Q1 | ameh |
Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageFairValue
|
0.01 | |
| CY2013 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2061728 | USD |
| CY2012Q1 | ameh |
Class Of Warrant Or Right Outstanding Intrinsic Value
ClassOfWarrantOrRightOutstandingIntrinsicValue
|
0 | USD |
| CY2013 | ameh |
Class Of Warrant Or Right Granted Intrinsic Value
ClassOfWarrantOrRightGrantedIntrinsicValue
|
0 | USD |
| CY2014 | ameh |
Class Of Warrant Or Right Granted Intrinsic Value
ClassOfWarrantOrRightGrantedIntrinsicValue
|
0 | USD |
| CY2013 | ameh |
Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
|
0 | USD |
| CY2014 | ameh |
Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
|
0 | USD |
| CY2013 | ameh |
Class Of Warrant Or Right Cancelled
ClassOfWarrantOrRightCancelled
|
0 | USD |
| CY2014 | ameh |
Class Of Warrant Or Right Cancelled
ClassOfWarrantOrRightCancelled
|
0 | USD |
| CY2013Q1 | ameh |
Class Of Warrant Or Right Outstanding Intrinsic Value
ClassOfWarrantOrRightOutstandingIntrinsicValue
|
0 | USD |
| CY2014 | ameh |
Warrants Issued In Connection With Notes Payable
WarrantsIssuedInConnectionWithNotesPayable
|
50936 | USD |
| CY2013 | ameh |
Reclassification Of Warrant Liabilities To Equity
ReclassificationOfWarrantLiabilitiesToEquity
|
6626881 | USD |
| CY2013 | ameh |
Issuance Of Common Stock Value In Payment Of Financing Cost
IssuanceOfCommonStockValueInPaymentOfFinancingCost
|
198935 | USD |
| CY2014 | ameh |
Issuance Of Common Stock Value In Payment Of Financing Cost
IssuanceOfCommonStockValueInPaymentOfFinancingCost
|
45000 | USD |
| CY2013 | ameh |
Warrants Issued In Connection With Notes Payable
WarrantsIssuedInConnectionWithNotesPayable
|
387349 | USD |
| CY2014 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
136751 | USD |
| CY2013 | us-gaap |
Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
|
5853855 | USD |
| CY2014 | us-gaap |
Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
|
0 | USD |
| CY2013 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
548899 | USD |
| CY2014 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-72916 | USD |
| CY2013 | us-gaap |
Increase Decrease In Due To Officers And Stockholders Current
IncreaseDecreaseInDueToOfficersAndStockholdersCurrent
|
-12400 | USD |
| CY2014 | us-gaap |
Increase Decrease In Due To Officers And Stockholders Current
IncreaseDecreaseInDueToOfficersAndStockholdersCurrent
|
0 | USD |
| CY2013 | us-gaap |
Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
|
-5504 | USD |
| CY2014 | us-gaap |
Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
|
-4049 | USD |
| CY2013 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
23666 | USD |
| CY2014 | us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-19084 | USD |
| CY2013 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
-7020 | USD |
| CY2014 | us-gaap |
Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
|
27700 | USD |
| CY2013 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
764208 | USD |
| CY2014 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
455738 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
57956 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1478205 | USD |
| CY2012Q1 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
1500000 | shares |
| CY2013 | ameh |
Number Of Warrants Granted
NumberOfWarrantsGranted
|
2936000 | shares |
| CY2014 | ameh |
Number Of Warrants Granted
NumberOfWarrantsGranted
|
209000 | shares |
| CY2014 | ameh |
Number Of Warrants Exercised
NumberOfWarrantsExercised
|
0 | shares |
| CY2013 | ameh |
Class Of Warrant Or Right Cancelled In Period
ClassOfWarrantOrRightCancelledInPeriod
|
-1500000 | shares |
| CY2014 | ameh |
Class Of Warrant Or Right Cancelled In Period
ClassOfWarrantOrRightCancelledInPeriod
|
0 | shares |
| CY2013Q1 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
2936000 | shares |
| CY2014Q1 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
3145000 | shares |
| CY2013 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
74393 | USD |
| CY2014 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
0 | USD |
| CY2013 | us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
89162 | USD |
| CY2014 | us-gaap |
Adjustment For Amortization
AdjustmentForAmortization
|
255396 | USD |
| CY2013 | us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
670697 | USD |
| CY2013 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
-14114 | USD |
| CY2014 | us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
250000 | USD |
| CY2013 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
45799 | USD |
| CY2014 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
22931 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-31685 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-272931 | USD |
| CY2013 | ameh |
Proceeds From Notes And Line Of Credit Payable
ProceedsFromNotesAndLineOfCreditPayable
|
594765 | USD |
| CY2014 | ameh |
Proceeds From Notes And Line Of Credit Payable
ProceedsFromNotesAndLineOfCreditPayable
|
2811878 | USD |
| CY2013 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
0 | USD |
| CY2014 | us-gaap |
Repayments Of Notes Payable
RepaymentsOfNotesPayable
|
530000 | USD |
| CY2013 | us-gaap |
Payments To Minority Shareholders
PaymentsToMinorityShareholders
|
400000 | USD |
| CY2013 | ameh |
Proceeds From Subscribed Common Stock
ProceedsFromSubscribedCommonStock
|
0 | USD |
| CY2014 | ameh |
Proceeds From Subscribed Common Stock
ProceedsFromSubscribedCommonStock
|
-730000 | USD |
| CY2013 | us-gaap |
Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
|
880000 | USD |
| CY2014 | us-gaap |
Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
|
220000 | USD |
| CY2013 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
104420 | USD |
| CY2014 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
258151 | USD |
| CY2013 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
986095 | USD |
| CY2014 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
2025816 | USD |
| CY2013 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
1012366 | USD |
| CY2014 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
274680 | USD |
| CY2012Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
164361 | USD |
| CY2013 | us-gaap |
Interest Paid
InterestPaid
|
160792 | USD |
| CY2014 | us-gaap |
Interest Paid
InterestPaid
|
247465 | USD |
| CY2013 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
9763 | USD |
| CY2014 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
19513 | USD |
| CY2014 | ameh |
Shares Issuable For Services
SharesIssuableForServices
|
0 | USD |
| CY2013 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
0 | USD |
| CY2014 | us-gaap |
Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
|
24783 | USD |
| CY2012Q1 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
-421220 | USD |
| CY2014 | ameh |
Reclassification Of Warrant Liabilities To Equity
ReclassificationOfWarrantLiabilitiesToEquity
|
0 | USD |
| CY2013 | us-gaap |
Notes Issued1
NotesIssued1
|
0 | USD |
| CY2014 | us-gaap |
Notes Issued1
NotesIssued1
|
299900 | USD |
| CY2014 | ameh |
Class Of Warrant Or Rights Grant In Period Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightsGrantInPeriodWeightedAverageRemainingContractualTerm
|
P3Y14D | |
| CY2014Q1 | ameh |
Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
|
3145000 | shares |
| CY2014Q1 | ameh |
Class Of Warrant Or Right Exercisable Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisableWeightedAverageExercisePriceOfWarrantsOrRights
|
0.2882 | |
| CY2014 | ameh |
Common Shares Issued And Outstanding
CommonSharesIssuedAndOutstanding
|
46952469 | shares |
| CY2014Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
|
1820000 | shares |
| CY2014 | us-gaap |
Nature Of Operations
NatureOfOperations
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify"><strong>1. Description of Business</strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif; font-size-adjust: none; font-stretch: normal" align="justify">Apollo Medical Holdings, Inc. and its affiliated physician groups are a physician- centric, integrated healthcare delivery system serving Medicare, Commercial and Medi-Cal beneficiaries in California. As of April 30, 2014, ApolloMed’s physician network consisted <font style="BACKGROUND-COLOR: transparent"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">of over 700</font></font> hospitalists, primary care physicians and specialist physicians primarily through our owned and affiliated physician groups. ApolloMed operates as a medical management holding company through the following subsidiary management companies: Apollo Medical Management, Inc. (“AMM”), Pulmonary Critical Care Management, Inc. (“PCCM”), Verdugo Medical Management, Inc. (“VMM”) and ApolloMed ACO, Inc. (“ApolloMed ACO”). Through AMM, PCCM, and VMM, the Company manages affiliated medical groups, which have been consolidated and include ApolloMed Hospitalists (“AMH"), Los Angeles Lung Center (“LALC”) and Eli Hendel, M.D., Inc. (“Hendel”). AMM, PCCM and VMM each operate as a physician practice management company (“PPM”) and are in the business of providing management services to physician practice corporations (“PPC”) under long-term management service agreements. ApolloMedACO participates in the Medicare Shared Savings Program (“MSSP”), the goal of which is to improve the quality of patient care and outcomes through a more efficient and coordinated approach among providers.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2014 | dei |
Document Type
DocumentType
|
10-K | |
| CY2014 | dei |
Amendment Flag
AmendmentFlag
|
false | |
| CY2014 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2014-01-31 | |
| CY2014 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2014 | |
| CY2014 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
FY | |
| CY2014 | dei |
Trading Symbol
TradingSymbol
|
AMEH | |
| CY2014Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
49134549 | shares |
| CY2014 | dei |
Entity Registrant Name
EntityRegistrantName
|
Apollo Medical Holdings, Inc. | |
| CY2014 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001083446 | |
| CY2014 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--01-31 | |
| CY2014 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
| CY2014 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
| CY2014 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
| CY2014 | dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Company | |
| CY2013Q3 | dei |
Entity Public Float
EntityPublicFloat
|
8073400 | USD |
| CY2013Q1 | us-gaap |
Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
|
0 | USD |
| CY2014Q1 | us-gaap |
Restricted Cash And Investments Current
RestrictedCashAndInvestmentsCurrent
|
20000 | USD |
| CY2013Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
0 | USD |
| CY2014Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
62427 | USD |
| CY2013Q1 | ameh |
Medical Payable
MedicalPayable
|
0 | USD |
| CY2014Q1 | ameh |
Medical Payable
MedicalPayable
|
285625 | USD |
| CY2013 | ameh |
Shares Issuable For Services
SharesIssuableForServices
|
159334 | USD |
| CY2013 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
15750 | USD |
| CY2014 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
0 | USD |
| CY2013 | us-gaap |
Stockholders Equity Other
StockholdersEquityOther
|
0 | USD |
| CY2013 | us-gaap |
Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
|
113096 | USD |
| CY2013 | us-gaap |
Minority Interest Period Increase Decrease
MinorityInterestPeriodIncreaseDecrease
|
-400000 | USD |
| CY2014 | us-gaap |
Minority Interest Period Increase Decrease
MinorityInterestPeriodIncreaseDecrease
|
-240000 | USD |
| CY2013 | ameh |
Adjustments To Additional Paid In Capital Warrant And Derivative Liabilities
AdjustmentsToAdditionalPaidInCapitalWarrantAndDerivativeLiabilities
|
6626881 | USD |
| CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
510642 | USD |
| CY2014 | us-gaap |
Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
|
50936 | USD |
| CY2013 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
1974070 | USD |
| CY2014 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
730975 | USD |
| CY2013 | ameh |
Adjustment To Additional Paid In Capital Share Based Compensation Non Vested Shares Requisite Service Period Recognition
AdjustmentToAdditionalPaidInCapitalShareBasedCompensationNonVestedSharesRequisiteServicePeriodRecognition
|
-616014 | USD |
| CY2014 | ameh |
Adjustment To Additional Paid In Capital Share Based Compensation Non Vested Shares Requisite Service Period Recognition
AdjustmentToAdditionalPaidInCapitalShareBasedCompensationNonVestedSharesRequisiteServicePeriodRecognition
|
333838 | USD |
| CY2013 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
709980 | USD |
| CY2014 | us-gaap |
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
|
1252378 | USD |
| CY2013 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
15750 | USD |
| CY2013Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
78822 | USD |
| CY2013 | us-gaap |
Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
|
74393 | USD |
| CY2014 | us-gaap |
Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
|
0 | USD |
| CY2013 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
-38147 | USD |
| CY2014 | us-gaap |
Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
|
-28348 | USD |
| CY2014Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
50474 | USD |
| CY2012Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
42576 | USD |
| CY2012Q2 | us-gaap |
Revenues
Revenues
|
1631844 | USD |
| CY2013Q2 | us-gaap |
Revenues
Revenues
|
2446566 | USD |
| CY2012Q3 | us-gaap |
Revenues
Revenues
|
1649451 | USD |
| CY2013Q3 | us-gaap |
Revenues
Revenues
|
2593046 | USD |
| CY2013Q4 | us-gaap |
Revenues
Revenues
|
2605231 | USD |
| CY2012Q4 | us-gaap |
Revenues
Revenues
|
1965153 | USD |
| CY2013Q1 | us-gaap |
Revenues
Revenues
|
2529683 | USD |
| CY2014Q1 | us-gaap |
Revenues
Revenues
|
2839462 | USD |
| CY2012Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-53153 | USD |
| CY2013Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-711972 | USD |
| CY2012Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-63026 | USD |
| CY2013Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1360387 | USD |
| CY2013Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-813487 | USD |
| CY2012Q4 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1437225 | USD |
| CY2013Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-525083 | USD |
| CY2014Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1024033 | USD |
| CY2012Q2 | ameh |
Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
|
123838 | USD |
| CY2013Q2 | ameh |
Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
|
0 | USD |
| CY2012Q3 | ameh |
Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
|
-2914549 | USD |
| CY2013Q3 | ameh |
Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
|
0 | USD |
| CY2013Q4 | ameh |
Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
|
0 | USD |
| CY2012Q4 | ameh |
Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
|
-3063144 | USD |
| CY2013Q1 | ameh |
Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
|
0 | USD |
| CY2014Q1 | ameh |
Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
|
0 | USD |
| CY2012Q2 | us-gaap |
Interest Expense
InterestExpense
|
224036 | USD |
| CY2013Q2 | us-gaap |
Interest Expense
InterestExpense
|
127493 | USD |
| CY2012Q3 | us-gaap |
Interest Expense
InterestExpense
|
224906 | USD |
| CY2013Q3 | us-gaap |
Interest Expense
InterestExpense
|
170806 | USD |
| CY2013Q4 | us-gaap |
Interest Expense
InterestExpense
|
178679 | USD |
| CY2012Q4 | us-gaap |
Interest Expense
InterestExpense
|
221239 | USD |
| CY2013Q1 | us-gaap |
Interest Expense
InterestExpense
|
259995 | USD |
| CY2014Q1 | us-gaap |
Interest Expense
InterestExpense
|
202206 | USD |
| CY2012Q2 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-5 | USD |
| CY2013Q2 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-246 | USD |
| CY2012Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
455 | USD |
| CY2013Q3 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-924 | USD |
| CY2012Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
29965878 | shares |
| CY2013Q4 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
9476 | USD |
| CY2012Q4 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
207 | USD |
| CY2013Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-37903 | USD |
| CY2014Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
41396 | USD |
| CY2013Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
34843441 | shares |
| CY2012Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
31015904 | shares |
| CY2013Q3 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
37977607 | shares |
| CY2013Q4 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
37977607 | shares |
| CY2012Q4 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
33440542 | shares |
| CY2013Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
34808001 | shares |
| CY2014Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
42084686 | shares |
| CY2012Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.01 | |
| CY2013Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.02 | |
| CY2012Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.10 | |
| CY2012Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4721401 | USD |
| CY2013Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-822981 | USD |
| CY2014Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1162996 | USD |
| CY2012Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-153356 | USD |
| CY2013Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-839711 | USD |
| CY2012Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-3202026 | USD |
| CY2013Q3 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-1532117 | USD |
| CY2013Q4 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-982690 | USD |
| CY2012Q4 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-4721401 | USD |
| CY2013Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-822981 | USD |
| CY2014Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-1184843 | USD |
| CY2012Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
4000 | USD |
| CY2013Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
9404 | USD |
| CY2012Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
800 | USD |
| CY2013Q3 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| CY2013Q4 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
31956 | USD |
| CY2012Q4 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| CY2013Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| CY2014Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
-21847 | USD |
| CY2012Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-157356 | USD |
| CY2013Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-849115 | USD |
| CY2012Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3202826 | USD |
| CY2013Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1532117 | USD |
| CY2013Q4 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-1014646 | USD |
| CY2013Q3 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.04 | |
| CY2013Q4 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.03 | |
| CY2012Q4 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.15 | |
| CY2013Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.02 | |
| CY2014Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.03 | |
| CY2013Q1 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
3967114 | USD |
| CY2014Q1 | us-gaap |
Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
|
3575748 | USD |
| CY2013Q1 | ameh |
Deferred Tax Assets Stock Option Exercisable
DeferredTaxAssetsStockOptionExercisable
|
741971 | USD |
| CY2014Q1 | ameh |
Deferred Tax Assets Stock Option Exercisable
DeferredTaxAssetsStockOptionExercisable
|
1164135 | USD |
| CY2013Q1 | us-gaap |
Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
|
8740 | USD |
| CY2014Q1 | us-gaap |
Deferred Tax Assets Charitable Contribution Carryforwards
DeferredTaxAssetsCharitableContributionCarryforwards
|
6018 | USD |
| CY2013Q1 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
|
0 | USD |
| CY2014Q1 | us-gaap |
Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves
|
0 | USD |
| CY2013Q1 | ameh |
State Income Taxes
StateIncomeTaxes
|
544 | USD |
| CY2014Q1 | ameh |
State Income Taxes
StateIncomeTaxes
|
272 | USD |
| CY2013Q1 | ameh |
Deferred Tax Assets Accrual To Cash
DeferredTaxAssetsAccrualToCash
|
-243300 | USD |
| CY2014Q1 | ameh |
Deferred Tax Assets Accrual To Cash
DeferredTaxAssetsAccrualToCash
|
-179000 | USD |
| CY2013Q1 | us-gaap |
Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
|
-310478 | USD |
| CY2014Q1 | us-gaap |
Deferred Tax Assets State Taxes
DeferredTaxAssetsStateTaxes
|
-403535 | USD |
| CY2014Q1 | us-gaap |
Operating Leases Future Minimum Payments Next Rolling Twelve Months
OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths
|
144416 | USD |
| CY2014Q1 | us-gaap |
Operating Leases Future Minimum Payments Due In Rolling Year Two
OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwo
|
121546 | USD |
| CY2013Q1 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
4164591 | USD |
| CY2014Q1 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
4163638 | USD |
| CY2013Q1 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
4164591 | USD |
| CY2014Q1 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
4163638 | USD |
| CY2014Q1 | us-gaap |
Operating Leases Future Minimum Payments Due In Rolling Year Three
OperatingLeasesFutureMinimumPaymentsDueInRollingYearThree
|
124294 | USD |
| CY2014Q1 | us-gaap |
Operating Leases Future Minimum Payments Due In Rolling Year Four
OperatingLeasesFutureMinimumPaymentsDueInRollingYearFour
|
30000 | USD |
| CY2013Q1 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
| CY2014Q1 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
| CY2014Q1 | us-gaap |
Operating Leases Future Minimum Payments Due In Rolling Year Five
OperatingLeasesFutureMinimumPaymentsDueInRollingYearFive
|
0 | USD |
| CY2014Q1 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
420256 | USD |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.0034 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
|
0.0034 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
|
-0.0006 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
|
-0.0018 | pure |
| CY2013 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
97402 | USD |
| CY2014 | us-gaap |
Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
|
-509890 | USD |
| CY2014 | us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims Current Year
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsCurrentYear
|
288601 | USD |
| CY2014 | ameh |
Stock Issued During Period Value Convertible Notes Redemption
StockIssuedDuringPeriodValueConvertibleNotesRedemption
|
864298 | USD |
| CY2014 | us-gaap |
Lease And Rental Expense
LeaseAndRentalExpense
|
210302 | USD |
| CY2013 | ameh |
Effective Income Tax Rate Reconciliation Non Deductible Expense Accrual To Cash
EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseAccrualToCash
|
0 | pure |
| CY2014 | ameh |
Effective Income Tax Rate Reconciliation Non Deductible Expense Accrual To Cash
EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseAccrualToCash
|
0 | pure |
| CY2013Q4 | ameh |
Professional Fee Payable Per Month
ProfessionalFeePayablePerMonth
|
15000 | USD |
| CY2013 | ameh |
Effective Income Tax Rate Reconciliation Non Deductible Expense Warrant Liability
EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseWarrantLiability
|
0 | pure |
| CY2014 | ameh |
Effective Income Tax Rate Reconciliation Non Deductible Expense Warrant Liability
EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseWarrantLiability
|
0 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
|
0 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseImpairmentLosses
|
0 | pure |
| CY2013 | ameh |
Effective Income Tax Rate Reconciliation Non Deductible Expense Non Cash Stock Compensation
EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseNonCashStockCompensation
|
0 | pure |
| CY2014 | ameh |
Effective Income Tax Rate Reconciliation Non Deductible Expense Non Cash Stock Compensation
EffectiveIncomeTaxRateReconciliationNonDeductibleExpenseNonCashStockCompensation
|
0 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
|
-0.0028 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense Other
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
|
-0.0016 | pure |
| CY2013 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
0 | pure |
| CY2014 | us-gaap |
Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
|
0 | pure |
| CY2013Q1 | us-gaap |
Salaries Wages And Officers Compensation
SalariesWagesAndOfficersCompensation
|
225000 | USD |
| CY2013Q1 | ameh |
Health Insurance Expense
HealthInsuranceExpense
|
1200 | USD |
| CY2014 | ameh |
Percentage For Reconveyance Owns Outstanding Shares
PercentageForReconveyanceOwnsOutstandingShares
|
0.5 | pure |
| CY2009Q4 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
25000 | USD |
| CY2009Q4 | us-gaap |
Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
|
25000 | shares |
| CY2014Q1 | ameh |
Warrant Expiration Date
WarrantExpirationDate
|
2014-10-31 | |
| CY2012Q1 | us-gaap |
Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
|
120000 | USD |
| CY2014 | ameh |
Payments For Convertible Notes Redemption
PaymentsForConvertibleNotesRedemption
|
707911 | USD |
| CY2013 | ameh |
Payments For Convertible Notes Redemption
PaymentsForConvertibleNotesRedemption
|
0 | USD |
| CY2014 | ameh |
Shares Issued In Connection With Notes Redemption
SharesIssuedInConnectionWithNotesRedemption
|
864298 | USD |
| CY2013 | ameh |
Shares Issued In Connection With Notes Redemption
SharesIssuedInConnectionWithNotesRedemption
|
0 | USD |
| CY2013Q4 | ameh |
Consulting Expenses Payable Per Month
ConsultingExpensesPayablePerMonth
|
2000 | USD |
| CY2012Q1 | us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Net
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
|
0 | USD |
| CY2013Q1 | us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Net
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
|
0 | USD |
| CY2013 | us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims Current Year
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsCurrentYear
|
0 | USD |
| CY2014 | us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims Prior Years
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYears
|
0 | USD |
| CY2013 | us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims Prior Years
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaimsPriorYears
|
0 | USD |
| CY2014 | us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims
|
288601 | USD |
| CY2013 | us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims
|
0 | USD |
| CY2014 | us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear
|
-2976 | USD |
| CY2013 | us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear
|
0 | USD |
| CY2014 | us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears
|
0 | USD |
| CY2013 | us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears
|
0 | USD |
| CY2014 | us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaid
|
-2976 | USD |
| CY2013 | us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaid
|
0 | USD |
| CY2014Q1 | us-gaap |
Liability For Unpaid Claims And Claims Adjustment Expense Net
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
|
285625 | USD |
| CY2014Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
|
16800 | USD |
| CY2014Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
|
16800 | USD |
| CY2014Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
|
16542 | USD |
| CY2014Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
|
9918 | USD |
| CY2014Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
|
2367 | USD |
| CY2014Q1 | us-gaap |
Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
|
0 | USD |
| CY2014Q1 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
68400 | USD |
| CY2013Q1 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
0 | USD |
| CY2014Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
5973 | USD |
| CY2013Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
0 | USD |
| CY2014 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
5973 | USD |
| CY2013 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
0 | USD |
| CY2012Q1 | us-gaap |
Goodwill
Goodwill
|
32000 | USD |
| CY2014 | us-gaap |
Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
|
461500 | USD |
| CY2013 | us-gaap |
Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
|
1200 | USD |
| CY2014Q1 | us-gaap |
Deferred Finance Costs Gross
DeferredFinanceCostsGross
|
586924 | USD |
| CY2013Q1 | us-gaap |
Deferred Finance Costs Gross
DeferredFinanceCostsGross
|
342631 | USD |
| CY2014Q1 | us-gaap |
Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
|
344773 | USD |
| CY2013Q1 | us-gaap |
Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
|
89377 | USD |
| CY2014Q1 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
242151 | USD |
| CY2013Q1 | us-gaap |
Deferred Finance Costs Net
DeferredFinanceCostsNet
|
253254 | USD |
| CY2014Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
438084 | USD |
| CY2013Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
389179 | USD |
| CY2014Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
352399 | USD |
| CY2013Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
321037 | USD |
| CY2014Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
|
150000 | USD |
| CY2014Q1 | us-gaap |
Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
|
950522 | USD |
| CY2013Q4 | ameh |
Debt Instrument Estimated Yield
DebtInstrumentEstimatedYield
|
0.186 | pure |
| CY2013Q4 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
950000 | USD |
| CY2012Q2 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
25661 | USD |
| CY2012Q4 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
50000 | USD |
| CY2013Q4 | us-gaap |
Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
|
3300000 | USD |
| CY2013Q4 | us-gaap |
Short Term Debt Refinanced Amount
ShortTermDebtRefinancedAmount
|
3700000 | USD |
| CY2009Q4 | ameh |
Warrant Expiration Date
WarrantExpirationDate
|
2014-10-31 | |
| CY2009Q4 | ameh |
Class Of Warrant Or Right Issued In Period
ClassOfWarrantOrRightIssuedInPeriod
|
1500000 | shares |
| CY2014 | ameh |
Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriodTotalIntrinsicValue
|
0 | USD |
| CY2013Q4 | us-gaap |
Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
|
1100000 | USD |
| CY2013Q4 | us-gaap |
Extinguishment Of Debt Amount
ExtinguishmentOfDebtAmount
|
218000 | USD |
| CY2014 | us-gaap |
Stockholders Equity Other Shares
StockholdersEquityOtherShares
|
500000 | shares |
| CY2014Q1 | ameh |
Common Stock Reserved For Future Issuance
CommonStockReservedForFutureIssuance
|
68207549 | shares |
| CY2014Q1 | ameh |
Common Stock Warrants Fair Value
CommonStockWarrantsFairValue
|
50937 | USD |
| CY2014 | us-gaap |
Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
|
509890 | USD |
| CY2013 | us-gaap |
Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
|
0 | USD |
| CY2012Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
|
0 | shares |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
5750000 | shares |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
0 | shares |
| CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
|
-3914815 | shares |
| CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
|
-822222 | shares |
| CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
|
0 | shares |
| CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
|
0 | shares |
| CY2013Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
|
1835185 | shares |
| CY2014Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
|
1012963 | shares |
| CY2012Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
|
0 | |
| CY2013 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
0.30 | |
| CY2014 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
0 | |
| CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
|
0.30 | |
| CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
|
0.21 | |
| CY2013 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
|
0 | |
| CY2014 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
|
0 | |
| CY2013Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
|
0.30 | |
| CY2014Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
|
0.41 | |
| CY2014Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
|
282176 | USD |
| CY2014 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P1Y6M | |
| CY2014 | us-gaap |
Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
|
11570305 | USD |
| CY2013 | us-gaap |
Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
|
9162131 | USD |
| CY2014 | us-gaap |
Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
|
-4526075 | USD |
| CY2013 | us-gaap |
Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
|
-8801564 | USD |
| CY2014 | ameh |
Business Acquisition Performa Earnings Per Share Basic And Diluted
BusinessAcquisitionPerformaEarningsPerShareBasicAndDiluted
|
-0.12 | |
| CY2013 | ameh |
Business Acquisition Performa Earnings Per Share Basic And Diluted
BusinessAcquisitionPerformaEarningsPerShareBasicAndDiluted
|
-0.27 | |
| CY2014 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
2157857 | USD |
| CY2014 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"><b>Reclassifications</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">Certain reclassifications have been made to the accompanying 2013 consolidated financial statements to conform them to the 2014 presentation.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2014 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
45000 | USD |
| CY2014 | ameh |
Settlement Of Stock Issuable Liability With Issuance Of Shares
SettlementOfStockIssuableLiabilityWithIssuanceOfShares
|
159334 | USD |
| CY2013 | ameh |
Settlement Of Stock Issuable Liability With Issuance Of Shares
SettlementOfStockIssuableLiabilityWithIssuanceOfShares
|
0 | USD |
